SCHEMBL19789312

SCHEMBL19789312

COc1c[nH]c(=O)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 6/20 0.46
CYP19A1 P11511 5/20 0.46
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KDM4E B2RXH2 1/20 0.38
TNKS2 Q9H2K2 1/20 0.37
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
CDK4 P11802 1/20 0.36
CCNA2 P20248 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845906 0.78 AR (0.35) NQO2CYP19A1MEN1KMT2AKDM4E
SCHEMBL15148389 0.77 GRIN2D (0.38) NQO2CYP19A1GRIN2DGRIN3BGRIN1
SCHEMBL16137887 0.77 GRIN2D (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL791112 0.74
SCHEMBL31702090 0.74 APP (0.38) NQO2CYP19A1GRIN2DGRIN3BGRIN1
SCHEMBL24837086 0.74 SCN8A (0.37) NQO2CYP19A1TNKS2
SCHEMBL33525781 0.72 ADRA1A (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL18327656 0.71 NR3C1 (0.44) NQO2CYP19A1MEN1KMT2AALDH1A1
SCHEMBL9178559 0.71 HDAC4 (0.41) NQO2CYP19A1GRIN2DGRIN3BGRIN1
SCHEMBL30859597 0.71 KDM4E (0.47) KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150474-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF DOGMA THERAPEUTICS, INC. (US) 2020-07-23 WO disclosed
EP-3272754-A1 IMIDAZOPYRROLIDINONE COMPOUNDS Novartis AG (CH) 2018-01-24 EP disclosed